Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Diisopropylamine | HCID 7912 | — |
| Reactant | Ethynylpyridine | HCID 137268 | — |
| Reactant | Tris(furan-2-yl)phosphane | HCID 521585 | — |
| Reactant | HCID 67417233 | HCID 67417233 | — |
| Catalyst | Palladium, di-mu-chlorobis(eta3-2-propenyl)di- | HCID 61538 | — |
| Catalyst | Copper iodide | HCID 83717 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Solvent | Acetonitrile | HCID 6342 | — |
| Solvent | Trifluoroacetic acid | HCID 6422 | — |
| Product | HCID 59375617 | HCID 59375617 | — |
Reaction Steps
9-bromo-4-iodo-6-(tetrahydro-2H-pyran-4-yl)benzo[c]-1,6-naphthyridin-1(2H)-one (50 mg, 0.10 mmol), di-mu-chlorobis[(eta-allyl)palladium(II)] (2.3 mg, 6.2 μmol), copper iodide (2.4 mg, 0.012 mmol) and tri(2-furyl)phosphine (2.9 mg, 0.012 mmol) were added to a vial, followed by acetonitrile (1.0 mL), diisopropylamine (44 uL, 0.71 mmol) and 2-ethynyl pyridine (32 mg, 0.31 mmol). The resulting suspension was heated to 45° C. and stirred for four hours. The reaction mixture was diluted with 4 mL DMF and 100 uL TFA, then purified directly by preparative reverse phase HPLC eluting with an acetonitrile/water gradient (with 0.05% TFA as a modifier) to afford 9-bromo-4-(pyridin-3-ylethynyl)-6-(tetrahydro-2H-pyran-4-yl)benzo[c]-1,6-naphthyridin-1(2H)-one. 1H NMR (500 MHz, DMSO-D6) δ 12.38 (br s, 1H), 10.28 (s, 1H), 8.75 (s, 1H), 8.56 (d, 1H), 8.54 (d, 1H), 8.09 (s, 1H), 7.93 (overlapping t, 2H), 7.49 (dd, 1H), 4.02 (overlapping m, 3H), 3.65 (t, 2H), 2.11 (m, 2H), 1.89 (d, 2H). LRMS (ESI) calc'd for (C24H18BrN3O2) [M+H]+, 460.1; found 460.0.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08329722B2 |
|---|
| Source dataset | uspto-grants-2012_12 |
|---|
| ORD ID | ord-1eb5a0bbacab423eb7e8c63883d86e93 |
|---|
| Source note | uspto-grants-2012_12 |
|---|